CellSeed Inc. is mainly engaged in the regenerative medical business. The Company operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.

Employees

Sector

Pharmaceuticals

Calendar

08-12 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
26-07-08	JP¥214.00	-3.60%	216,000
26-07-07	JP¥222.00	-3.06%	155,700
26-07-06	JP¥229.00	-1.72%	246,400
26-07-03	JP¥233.00	+3.10%	205,800
26-07-02	JP¥226.00	+1.80%	251,600

Delayed Quote Japan Exchange

More quotes

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-07-08 EDT			5-day change	1st Jan Change
214.00 ^JPY	-3.60%		-0.93%	-17.37%

12-07	CellSeed Inc. announced that it has received ¥3.44 million in funding from Barclays Bank PLC, Investment Arm	CI
11-20	CellSeed Inc. announced that it expects to receive ¥3.44 million in funding from Barclays Bank PLC, Investment Arm	CI

Market Cap	4.1B 25.34M 22.18M 20.44M 18.94M 35.96M 2.4B 36.54M 245M 95.3M 1.19B 95.13M 93.07M	P/E 2020	-4.47x	P/E 2021	-3.46x
Enterprise Value	3.33B 20.58M 18.01M 16.6M 15.38M 29.2M 1.95B 29.67M 199M 77.39M 964M 77.25M 75.58M	EV / Sales 2020	12.4x	EV / Sales 2021	15.5x
Free-Float	98.55%	Yield 2020 *	-	Yield 2021	-

12-07	CellSeed Inc. announced that it has received ¥3.44 million in funding from Barclays Bank PLC, Investment Arm	CI
11-20	CellSeed Inc. announced that it expects to receive ¥3.44 million in funding from Barclays Bank PLC, Investment Arm	CI
24-09-22	CellSeed Inc.(TSE:7776) added to S&P Global BMI Index	CI
23-06-04	CellSeed Inc. announced that it has received ¥2.001 million in funding from Barclays Bank PLC, Investment Arm	CI
23-05-14	CellSeed Inc. announced that it expects to receive Â¥2.001 million in funding from Barclays Bank PLC, Investment Arm	CI
22-01-04	CellSeed Inc. announced that it has received ¥1.144 million in funding from Barclays Bank PLC, Investment Arm	CI
21-12-19	CellSeed Inc. announced that it expects to receive ¥1.144 million in funding from Barclays Bank PLC, Investment Arm	CI
20-08-05	CellSeed Inc. announced that it has received ¥3.78 million in funding from Barclays Bank PLC, Investment Arm	CI
20-07-20	CellSeed Inc. announced that it expects to receive ¥3.78 million in funding from Barclays Bank PLC, Investment Arm	CI
19-09-01	CellSeed Inc. announced that it has received ¥2.884 million in funding	CI
19-08-13	An unknown buyer acquired 0.34% stake in CellSeed Inc. from Emmaus Life Sciences, Inc. for $0.22 million.	CI
19-08-13	CellSeed Inc. announced that it expects to receive ¥2.884 million in funding	CI
17-03-05	CellSeed Inc. announced that it has received ¥6.6 million in funding from Evolution Capital Management, LLC	CI

1 day	-3.60%
1 week	-0.93%
Current month	-0.93%
1 month	-7.36%
3 months	-24.91%
6 months	-25.17%
Current year	-17.37%

CellSeed Inc. Stock

Stocks

7776

JP3423530009

Pharmaceuticals

Valuation: CellSeed Inc.

Chart: CellSeed Inc.

Latest news : CellSeed Inc.

Quotes and Performance

Course Extremes

Managers and Directors: CellSeed Inc.

Biopharmaceuticals

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Setsuko Hashimoto PSD	President	72	2014-05-31
Keiichiro Nakaoka IRC	Investor Relations Contact	50	2019-09-30
Toshihiro Maeda PRN	Corporate Officer/Principal	70	2017-09-30

Director	Title	Age	Since
Setsuko Hashimoto BRD	Director/Board Member	72	2014-02-28
Kenji Oeda BRD	Director/Board Member	74	2017-02-28
Sachiko Endo BRD	Director/Board Member	72	2023-02-28

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CELLSEED INC.	-3.60%	-0.93%	-53.98%	-23.57%	53.7M
REGENERON PHARMACEUTICALS, INC.	-2.08%	+6.21%	+21.13%	-5.67%	68.8B
UCB	-2.01%	-3.57%	+46.21%	+217.06%	55.21B
SAMSUNG BIOLOGICS CO.,LTD.	-4.15%	+36.30%	+36.30%	+36.30%	43.46B
CSL LIMITED	+0.27%	+8.33%	-49.87%	-53.43%	41.18B
MODERNA, INC.	-7.15%	+2.39%	+128.12%	-39.69%	31.65B
BIOGEN INC.	-3.08%	-4.75%	+48.57%	-29.05%	30.37B
INCYTE CORPORATION	-1.07%	+2.59%	+72.54%	+88.66%	23.58B
INNOVENT BIOLOGICS, INC.	-1.15%	+8.29%	+4.42%	+184.96%	19.33B
SWEDISH ORPHAN BIOVITRUM AB	-1.33%	+1.11%	+66.11%	+131.83%	17.16B
Average	-2.54%	+3.64%	+31.95%	+50.74%	33.08B
Weighted average by Cap.	-2.46%	+3.54%	+36.24%	+50.66%

	2020	2021
Net sales	199M 1.23M 1.08M 991K 919K 1.74M 117M 1.77M 11.89M 4.62M 57.57M 4.61M 4.51M	161M 994K 870K 802K 743K 1.41M 94.38M 1.43M 9.62M 3.74M 46.58M 3.73M 3.65M
Net income	-783M -4.84M -4.23M -3.9M -3.62M -6.86M -459M -6.97M -46.77M -18.19M -227M -18.16M -17.76M	-914M -5.65M -4.94M -4.55M -4.22M -8.01M -536M -8.14M -54.6M -21.23M -264M -21.2M -20.74M
Net Debt	-1.3B -8.03M -7.03M -6.48M -6M -11.39M -762M -11.58M -77.65M -30.2M -376M -30.15M -29.49M	-771M -4.76M -4.17M -3.84M -3.56M -6.76M -452M -6.87M -46.05M -17.91M -223M -17.88M -17.49M

1 week	214	239
1 month	201	239
Current year	201	416
1 year	201	518
3 years	201	1,160
5 years	122	1,160
10 years	122	2,020